a public good project by the
Synthesis
Company
of California

© 2026

Eberle Mc | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Eberle Mc

Institut de Recherche en Cancérologie de Montpellier(FR)

Research Areas

Thyroid Cancer Diagnosis and Treatment, BRCA gene mutations in cancer, PI3K/AKT/mTOR signaling in cancer

Most-Cited Works

→ Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer(2018)33 cited